Upload Avatar (500 x 500)
Gangjian Qin
qingj@sustech.edu.cn
English, Chinese
Guangdong
Southern University of Science and Technology
Medical School
  • 1981-1986 Bachelor of Medicine, Tongji Medical University
  • 1986-1989 Master of Medicine, Tongji Medical University
  • Published over 130 original research papers
  • 1989-1992 Resident Physician, Tongji Medical University Hospital
  • 1992-1995 Attending Physician and Medical Lecturer, Tongji Medical University Hospital
  • 1995-1998 Postdoctoral Researcher, International Centre for Genetic Engineering and Biotechnology, Italy
  • 1998-2001 Postdoctoral Researcher, University of Illinois at Chicago, USA
  • 2001-2006 Medical Lecturer and Assistant Professor, Tufts University, Boston
  • 2007-2016 Assistant Professor and Associate Professor, Northwestern University, Chicago
  • 2016-2022 Professor and Director of Molecular Cardiology, University of Alabama, Birmingham
  • 2022-present Chair Professor, Southern University of Science and Technology, Shenzhen
  • 2004 Melvin Marcus Young Investigator Award in Cardiovascular Sciences, Finalist
  • 2007 Investigators Developing Excellence in Academics Award, Northwestern University
  • 2007 Searle Fellow for Teaching Excellence, Northwestern University
  • 2010 Honorary Member, American Heart Association (FAHA)
  • 2018-2020 Chair, American Cardiovascular Excellence Research Institute (ACRE)
  • 2022 Shenzhen Pengcheng Special Appointment (Category A)
Ischemic injury, organ protection and repair
Myocardial regeneration
Stem cells and their therapeutic translation
Glucose and lipid metabolism
  • Variegation of retroviral vector gene expression in myeloid cells, Zentilin L., Qin G., Tafuro S., Dinauer M.C., Baum C., Giacca M., 2000
  • Preselective gene therapy for Fabry disease, Qin G., Takenaka T., Telsch K., Kelley L., Howard T., Levade T., Deans R., Howard B.H., Malech H.L., Brady R.O., Medin J.A., 2001
  • Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction, Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D.H., Johnson K.L., Aikawa R., Asahara T., Losordo D.W., 2005
  • The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A, Kishore R., Qin G., Luedemann C., Bord E., Hanley A., Silver M., Gavin M., Yoon Y.S., Goukassian D., Losordo D.W., 2005
  • Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy, Ii M., Nishimura H., Kusano K.F., Qin G., Yoon Y.S., Wecker A., Asahara T., Losordo D.W., 2005
  • Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization, Qin G., Ii M., Silver M., Wecker A., Bord E., Ma H., Gavin M., Goukassian D.A., Yoon Y.S., Papayannopoulou T., Asahara T., Kearney M., Thorne T., Curry C., Eaton L., Heyd L., Dinesh D., Kishore R., Zhu Y., Losordo D.W., 2006
  • Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9, Iwakura A., Shastry S., Luedemann C., Hamada H., Kawamoto A., Kishore R., Zhu Y., Qin G., Silver M., Thorne T., Eaton L., Masuda H., Asahara T., Losordo D.W., 2006
  • Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF, Qin G., Kishore R., Dolan C., Silver M., Wecker A., Luedemann C.N., Thorne T., Hanley A., Curry C., Heyd L., Dinesh D., Kearney M., Martelli F., Murayama T., Goukassian D.A., Zhu Y., Losordo D.W., 2006
  • Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction, Hamada H., Kim M.K., Iwakura A., Ii M., Thorne T., Qin G., Asai J., Tsutsumi Y., Sekiguchi H., Silver M., Wecker A., Bord E., Zhu Y., Kishore R., Losordo D.W., 2006
  • Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization, Goukassian D.A., Qin G., Dolan C., Murayama T., Silver M., Curry C., Eaton E., Luedemann C., Ma H., Asahara T., Zak V., Mehta S., Burg A., Thorne T., Kishore R., Losordo D.W., 2007
Ischemia Organ Protection Tissue Repair Myocardial Regeneration Stem Cells Therapeutic Translation Glucose Metabolism Lipid Metabolism Cardiovascular

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.